Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Million)
1.2.1. Pet Cancer Therapeutics Market, by Region, 2019-2027 (USD Million)
1.2.2. Pet Cancer Therapeutics Market, by Therapy,2019-2027 (USD Million)
1.2.3. Pet Cancer Therapeutics Market, by Animal,2019-2027 (USD Million)
1.2.4. Pet Cancer Therapeutics Market, by Application, 2019-2027 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Pet Cancer Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Pet Cancer Therapeutics Market Dynamics
3.1. Pet Cancer Therapeutics Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Prevalence of several types of cancers in cats and dogs
3.1.1.2. Increase in animal health awareness
3.1.2. Market Restraint
3.1.2.1. Side effects caused by drugs used for the treatment of pet cancers
3.1.3. Market Opportunities
3.1.3.1. R&D initiatives regarding pet cancer management
Chapter 4. Global Pet Cancer Therapeutics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Pet Cancer Therapeutics Market, by Therapy
a. Market Snapshot
5.1. Global Pet Cancer Therapeutics Market by Therapy, Performance - Potential Analysis
5.2. Global Pet Cancer Therapeutics Market Estimates & Forecasts byTherapy 2018-2027 (USD Million)
5.3. Pet Cancer Therapeutics Market, Sub Segment Analysis
5.3.1. Chemotherapy
5.3.2. Radiation therapy
5.3.3. Immunotherapy
5.3.4. Others
Chapter 6. Global Pet Cancer Therapeutics Market, by Animal
6.1. Market Snapshot
6.2. Global Pet Cancer Therapeutics Market by Animal, Performance - Potential Analysis
6.3. Global Pet Cancer Therapeutics Market Estimates & Forecasts by Animal 2018-2027 (USD Million)
6.4. Pet Cancer Therapeutics Market, Sub Segment Analysis
6.4.1. Dogs
6.4.2. Cats
6.4.3. Others
Chapter 7. Global Pet Cancer Therapeutics Market, by Application
7.1. Market Snapshot
7.2. Global Pet Cancer Therapeutics Market by Application, Performance - Potential Analysis
7.3. Global Pet Cancer Therapeutics Market Estimates & Forecasts by Application 2018-2027 (USD Million)
7.4. Pet Cancer Therapeutics Market, Sub Segment Analysis
7.4.1. Lymphoma
7.4.2. Mast Cell Cancer
7.4.3. Melanoma
7.4.4. Mammary and Squamous Cell Cancer
7.4.5. Others
Chapter 8. Global Pet Cancer Therapeutics Market, Regional Analysis
8.1. Pet Cancer Therapeutics Market, Regional Market Snapshot
8.2. North America Pet Cancer Therapeutics Market
8.2.1. U.S.Pet Cancer Therapeutics Market
8.2.1.1. Therapy breakdown estimates & forecasts, 2018-2027
8.2.1.2. Animal breakdown estimates & forecasts, 2018-2027
8.2.1.3. Applicationbreakdown estimates & forecasts, 2018-2027
8.2.2. CanadaPet Cancer Therapeutics Market
8.3. Europe Pet Cancer Therapeutics Market Snapshot
8.3.1. U.K. Pet Cancer Therapeutics Market
8.3.2. Germany Pet Cancer Therapeutics Market
8.3.3. France Pet Cancer Therapeutics Market
8.3.4. Spain Pet Cancer Therapeutics Market
8.3.5. Italy Pet Cancer Therapeutics Market
8.3.6. Rest of EuropePet Cancer Therapeutics Market
8.4. Asia-PacificPet Cancer Therapeutics Market Snapshot
8.4.1. China Pet Cancer Therapeutics Market
8.4.2. India Pet Cancer Therapeutics Market
8.4.3. JapanPet Cancer Therapeutics Market
8.4.4. Australia Pet Cancer Therapeutics Market
8.4.5. South Korea Pet Cancer Therapeutics Market
8.4.6. Rest of Asia PacificPet Cancer Therapeutics Market
8.5. Latin America Pet Cancer Therapeutics Market Snapshot
8.5.1. Brazil Pet Cancer Therapeutics Market
8.5.2. Mexico Pet Cancer Therapeutics Market
8.6. Rest of The World Pet Cancer Therapeutics Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. AB Science
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. ProductSummary
9.2.1.5. Recent Developments
9.2.2. AdvaVet Inc.
9.2.3. Boehringer Ingelheim GmbH (Merial)
9.2.4. Elanco
9.2.5. ELIAS Animal Health
9.2.6. Karyopharm Therapeutics, Inc.
9.2.7. Rhizen Pharmaceuticals SA
9.2.8. Torigen Pharmaceuticals Inc.
9.2.9. VetDC Inc.
9.2.10. Virbac

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption